Spots Global Cancer Trial Database
Every month we try and update this database with cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma | NCT03298451 | Hepatocellular ... | Durvalumab Tremelimumab (R... Tremelimumab (R... Sorafenib Durvalumab (Reg... Durvalumab (Reg... | 18 Years - 100 Years | AstraZeneca | |
| Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant | NCT00305851 | Malignant Neopl... | Music Therapy Psychosocial As... Quality-of-Life... | 11 Years - 24 Years | Children's Oncology Group | |
| Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC | NCT01963351 | Non-small Cell ... Unresectable Ma... | 18 Years - | University of Athens | ||
| Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer | NCT00756951 | Oral Mucositis Head and Neck C... | Placebo SCV-07 SCV-07 | 18 Years - | SciClone Pharmaceuticals | |
| Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment | NCT05985551 | Breast Cancer Chemotherapy Ef... Sentinel Lymph ... | SLND or TAD by ... | 18 Years - | Uppsala University | |
| Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma | NCT05659251 | Esophageal Squa... Neoadjuvant The... | Serplulimab, Al... Esophagectomy sample | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Nerve Mobilization Techniques After Breast Cancer Surgery | NCT03250351 | Breast Cancer F... | Neural mobiliza... Control group | 20 Years - 70 Years | University of Alcala | |
| To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma | NCT04365751 | Hepatocellular ... | Percutaneous mi... | 18 Years - | Chinese PLA General Hospital | |
| Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies | NCT00473551 | Leukemia Lymphoma Myeloma | Rituximab Cyclophosphamid... Fludarabine Mesna Radiation Treat... Stem Cell Trans... Sirolimus Anti-third Part... | 18 Years - 70 Years | M.D. Anderson Cancer Center | |
| Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma | NCT01356251 | Mesothelioma | Questionnaires ... Questionnaires ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Immediate Breast Reconstruction's Increasing | NCT04888351 | Breast Reconstr... Breast Cancer | Comparison of c... To analyze vari... | 18 Years - | Hospices Civils de Lyon | |
| Determining the Optimal Examined Lymph Node for Accurate Staging and Long-term Survival in Rectal Cancer | NCT05572151 | Rectal Cancer | lymph node numb... | 18 Years - 90 Years | The Second Affiliated Hospital of Harbin Medical University | |
| Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies | NCT02743351 | Hematologic Mal... Acute Myeloid L... Acute Lymphobla... Myelodysplastic... Chronic Myeloge... Acute Graft-ver... | ProTmune Control Arm | 18 Years - | Fate Therapeutics | |
| Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy | NCT06435351 | Breast Cancer Triple Negative... | Leukapheresis Dendritic Cell ... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Muscadine Grape Extract to Improve Fatigue | NCT04495751 | Fatigue | Muscadine grape... Placebo Quality of Life... Questionnaires Participant Fee... | 65 Years - | Wake Forest University Health Sciences | |
| Frequency and Risk Factors of Acute Myeloid Leukemia | NCT05787951 | Myeloid Leukemi... | Bone marrow asp... | 18 Years - 80 Years | Assiut University | |
| C2 CryoBalloon™ 180 Ablation System Dose De-escalation Study. | NCT03311451 | Barrett Esophag... | C2 CryoBalloon ... | 18 Years - | Pentax Medical | |
| Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections | NCT00418951 | Acute Myelogeno... Myelodysplastic... | Voriconazole Liposomal ampho... Liposomal ampho... | 18 Years - | M.D. Anderson Cancer Center | |
| Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery | NCT03455751 | Colorectal Canc... Diverticular Di... Crohn Disease Ulcerative Coli... | PGx-guided post... | 18 Years - 80 Years | The Cleveland Clinic | |
| Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | NCT00363051 | Islet Cell Carc... Neuroendocrine ... Neuroendocrine ... Pancreatic Neop... | Everolimus 10 m... Octreotide Depo... | 18 Years - | Novartis | |
| Translational Research Center in Lung Cancer Disparities (TRACER) Project 2 | NCT05490251 | Smoking Smoking Behavio... Smoking Cessati... Stress Reaction | 18 Years - 75 Years | Virginia Commonwealth University | ||
| Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer | NCT01551251 | Advanced Nonsma... | 20 Years - | Chang Gung Memorial Hospital | ||
| GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer | NCT01553851 | Neoplasms, Oral Mouth Neoplasms | GSK1120212 | 18 Years - | Washington University School of Medicine | |
| A Study of Pembrolizumab in Patients With Neuroendocrine Tumors | NCT02939651 | Neuroendocrine ... | Pembrolizumab | 18 Years - | Fox Chase Cancer Center | |
| Charité HT-Prostate | NCT04159051 | Prostate Cancer Recurrence | Regional Hypert... | 18 Years - 80 Years | Charite University, Berlin, Germany | |
| Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma | NCT06185751 | Multiple Myelom... | WS-CART-CS1 Lymphodepleting... | 18 Years - | Washington University School of Medicine | |
| SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract | NCT00006351 | Bladder Cancer Transitional Ce... Urethral Cancer | gemcitabine hyd... lonafarnib | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study | NCT04242251 | Cancer | SPARKLE Model o... | 21 Years - 120 Years | National Cancer Centre, Singapore | |
| Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 | NCT04777851 | Carcinoma, Hepa... | Regorafenib in ... Loco-regional t... | 18 Years - | Translational Research in Oncology | |
| Temozolomide as Maintenance Therapy in Small Cell Lung Cancer | NCT01900951 | Carcinoma, Smal... | Temozolomide | 18 Years - 75 Years | Chinese PLA General Hospital | |
| Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma | NCT04511351 | Lymphoma | Chidamide | 18 Years - | ChineseAMS | |
| Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina | NCT03059251 | Chronic Lymphoc... | Obinutuzumab | 18 Years - | Hoffmann-La Roche | |
| Cetuximab Plus P-HDFL for the First-line Treatment of Advanced Gastric Cancer | NCT00275951 | Gastric Cancer | Cetuximab Plus ... | 18 Years - 75 Years | National Taiwan University Hospital | |
| Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation | NCT04621851 | Chronic Myeloid... | 18 Years - | University of Milano Bicocca | ||
| Prostate Metabolism, Cancer Risk and Gut Microbiota | NCT06116851 | Prostate Cancer Prostate Hyperp... | MRI scan and la... Prostate biopsi... Radical prostat... TURP and blood,... Radical cystopr... | 18 Years - | Turku University Hospital | |
| E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer | NCT04476251 | Uterine Cervica... | E7 T-Cell Recep... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer | NCT01642251 | Extensive Stage... Large Cell Lung... Neuroendocrine ... Small Cell Carc... Stage IV Non-Sm... | Cisplatin Etoposide Veliparib Placebo | 18 Years - | National Cancer Institute (NCI) | |
| Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial | NCT04820751 | Viral Pneumonia Serotonin Syndr... Platelet Dysfun... | Cyproheptadine ... | 18 Years - 99 Years | Ciusss de L'Est de l'Île de Montréal | |
| CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma | NCT00634751 | Pancreatic Neop... Bile Duct Neopl... | Oxaliplatin Capecitabine Sorafenib | 18 Years - | University of Wisconsin, Madison | |
| Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | NCT00012051 | Lymphoma | filgrastim rituximab carmustine cisplatin cytarabine dexamethasone etoposide ifosfamide melphalan methotrexate bone marrow abl... peripheral bloo... radiation thera... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients | NCT01370551 | Atrophic Vagini... | Gynoflor | 52 Years - 75 Years | Medinova AG | |
| Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain | NCT05588453 | Clinical Stage ... Metastatic Mali... Metastatic Mela... Pathologic Stag... | Natural Killer ... Temozolomide | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer | NCT03613753 | Small-cell Lung... | irinotecan plus... irinotecan | 18 Years - 70 Years | Guizhou Medical University | |
| Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL | NCT02572453 | Recurrent Anapl... Recurrent Diffu... Recurrent Mantl... Recurrent Trans... Refractory Anap... Refractory Diff... Refractory Mant... Refractory Tran... | Onalespib | 18 Years - | National Cancer Institute (NCI) | |
| A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer | NCT02135653 | Prostate Cancer | Radiotherapy Eischens Yoga | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors | NCT02276053 | Brain Tumor Rel... | 16 Years - | UCB Pharma | ||
| Prevention of Colorectal Cancer Through Multiomics Blood Testing | NCT04369053 | Colon Cancer Rectal Cancer Colon Neoplasm Colon Diseases Colon Lesion Colon Polyp Colorectal Canc... Polyp Adenoma Rectal Diseases Gastrointestina... | Freenome test | 45 Years - 85 Years | Freenome Holdings Inc. | |
| Phase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following Treatment | NCT02047253 | Metastatic Cast... | Carfilzomib Dexamethasone Acyclovir | 19 Years - | University of Alabama at Birmingham | |
| Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation | NCT02339753 | Pediatric Solid... | Carboplatin | - 19 Years | The Korean Society of Pediatric Hematology Oncology | |
| Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer | NCT02289053 | Colorectal Canc... Colon Polyps Adenomatous Pol... | 40 Years - 49 Years | University of Michigan | ||
| A Trial of SHR-A1912 Combined With Other Therapies in B-cell Non-Hodgkin 's Lymphoma | NCT06104553 | B-cell Non-Hodg... | SHR-A1912; R-Ch... SHR-A1912; R-Ch... | 18 Years - | Shanghai Hengrui Pharmaceutical Co., Ltd. | |
| Palliative Short Course Radiotherapy for Advanced Thoracic Cancer | NCT03465553 | Palliative Care | Short course ra... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery | NCT00365053 | Advanced Malign... Epithelial Meso... Recurrent Malig... Sarcomatous Mes... | belinostat laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients | NCT00411853 | Hormone Refract... | Fermented Wheat... | 18 Years - | Sheba Medical Center | |
| Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors | NCT03911453 | Breast Cancer | Rucaparib | 21 Years - | University of Arizona | |
| Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer | NCT00614653 | Pancreatic Canc... | Bevacizumab Erlotinib Capecitabine Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis | NCT04847453 | AL Amyloidosis | Biospecimen Col... Bone Marrow Asp... Computed Tomogr... Dexamethasone Ixazomib Citrat... Magnetic Resona... Positron Emissi... Transabdominal ... Venetoclax X-Ray Imaging | 18 Years - | National Cancer Institute (NCI) | |
| Physical Activity Intervention Trial to Mitigate Muscle Loss and Increase Muscle Strength | NCT02774551 | Oesophageal Can... | Physical activi... | 18 Years - | Karolinska Institutet | |
| Incidence and Risk Factors of Early Onset Colorectal Cancer | NCT05184751 | Colorectal Neop... | colonoscopy | 4 Years - 97 Years | Hospital Frydek-Mistek | |
| Multimodality Phase II Study in Prostate Cancer | NCT00734851 | Prostate Cancer | Docetaxel Sunitinib EBXRT | 18 Years - | Duke University | |
| Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC | NCT05228951 | Breast Cancer | Pyrotinib malea... | 18 Years - 75 Years | Shengjing Hospital | |
| Non-contrast Abbreviated MRI for Secondary Surveillance of HCC | NCT05690451 | Hepatocellular ... | non-contrast ab... Contrast enhanc... | 20 Years - 85 Years | Seoul National University Hospital | |
| A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors | NCT00503451 | Non-Hodgkin Lym... Neoplasms | LBH589 | 18 Years - | Novartis | |
| Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)in Combination With Docetaxel for the Treatment of Non-Small Cell Lung Cancer | NCT00405951 | Lung Cancer | Obatoclax mesyl... Docetaxel | 18 Years - | Teva Branded Pharmaceutical Products R&D, Inc. | |
| Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer | NCT03789851 | Breast Cancer | core needle bio... | 18 Years - | Shandong Cancer Hospital and Institute | |
| Search for Predictors of Therapeutic Response in Ovarian Carcinoma | NCT01391351 | Carcinoma of th... Fallopian Tube ... Peritoneal Sero... | blood samples blood samples | 18 Years - | Centre Francois Baclesse | |
| Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection | NCT04044651 | Hepatocellular ... | Lenvatinib Nivolumab | 18 Years - | Sun Yat-sen University | |
| A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100) | NCT02493751 | Renal Cell Canc... | Avelumab (MSB00... Axitinib (AG-01... | 18 Years - | Pfizer | |
| Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients | NCT02431351 | Myelodysplastic... | Selinexor | 18 Years - | Karyopharm Therapeutics Inc | |
| Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy | NCT01396551 | Lung Cancer | Implantation of... | 18 Years - | Varian, a Siemens Healthineers Company | |
| A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy | NCT00608751 | Head and Neck C... | IMRT | 18 Years - | Washington University School of Medicine | |
| Pretreatment Lymphocyte Monocyte Ratio on Outcome HCC Patients | NCT03869151 | Hepatocellular ... | CBC | 20 Years - 80 Years | Assiut University | |
| Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome | NCT05041751 | Breast Carcinom... | Acupuncture Poi... Massage Therapy Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | NCT00006051 | Head and Neck C... | cisplatin fluorouracil radiation thera... | 18 Years - 70 Years | UNICANCER | |
| Study of DSP-0390 in Patients With Recurrent High-Grade Glioma | NCT05023551 | High Grade Glio... Glioblastoma Mu... | DSP-0390 | 18 Years - | Sumitomo Pharma America, Inc. | |
| Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy | NCT02866851 | Cancer | Monitoring by W... | 18 Years - | Institut Cancerologie de l'Ouest | |
| Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00408551 | Colorectal Canc... Metastatic Canc... | floxuridine fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas | NCT00612651 | Gliosarcoma Glioblastoma Anaplastic Astr... | Temodar and SCH... | 18 Years - | Duke University | |
| Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma | NCT05940051 | Diffuse Large B... | Zanubrutinib, P... | 18 Years - 80 Years | Shanghai Zhongshan Hospital | |
| Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer | NCT01952951 | Rectal Neoplasm... Adenocarcinoma | Capecitabine Ox... pelvic radiatio... | 20 Years - | National Cancer Center, Korea |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
